2-dibenzofuran-4-yl-4-[4-(6-phenyldibenzofuran-3-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazine
C51H31N3O2 — CID 177269991
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-dibenzofuran-4-yl-4-[4-(6-phenyldibenzofuran-3-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazine
2-dibenzofuran-4-yl-4-[4-(6-phenyldibenzofuran-3-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazine (PubChem CID 177269991) has the molecular formula C51H31N3O2 and a molecular weight of 717.83 g/mol. Its IUPAC name is 2-dibenzofuran-4-yl-4-[4-(6-phenyldibenzofuran-3-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazine.
Molecular Properties
| Compound Name | 2-dibenzofuran-4-yl-4-[4-(6-phenyldibenzofuran-3-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazine |
|---|---|
| PubChem CID | 177269991 |
| Molecular Formula | C51H31N3O2 |
| Molecular Weight | 717.83 g/mol |
| Exact Mass | 717.24 |
| IUPAC Name | 2-dibenzofuran-4-yl-4-[4-(6-phenyldibenzofuran-3-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazine |
| SMILES | c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccc6c(c5)oc5c(-c7ccccc7)cccc56)cc4)nc(-c4cccc5c4oc4ccccc45)n3)cc2)cc1 |
| InChI | InChI=1S/C51H31N3O2/c1-3-11-32(12-4-1)33-21-25-36(26-22-33)49-52-50(54-51(53-49)44-19-10-18-42-40-15-7-8-20-45(40)55-48(42)44)37-27-23-34(24-28-37)38-29-30-41-43-17-9-16-39(35-13-5-2-6-14-35)47(43)56-46(41)31-38/h1-31H |
| InChIKey | JOGMFCPQOJZYMQ-UHFFFAOYSA-N |
| XLogP | 13.67 |
| TPSA | 64.95 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 56 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 717.83 |
| LogP ≤ 5 | 13.67 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177269991 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.